Biomanufacturing in vaccine industry - by UVU Bio NPC
Health & Pharma
Information
Company Description
UVU Bio NPC is a biotechnology innovation platform that supports skills development, venture growth, product development, and commercialization in Africa. Through open-access laboratory infrastructure, technical expertise, business support, and entrepreneur training in South Africa and Rwanda, UVU Bio helps early-stage and growing biotech ventures build capability, advance toward market readiness, and unlock investment and industry impact.
Countries of Operation
South Africa, Rwanda
Ownership of Company
Local
Number of years since incorporated
6
Project Pitch
UVU Bio proposes a vaccine manufacturing platform that combines open-access laboratory infrastructure, technical expertise, enterprise development, and skills training to strengthen Rwanda’s health and pharmaceutical ecosystem. The model supports early-stage innovators, SMEs, and emerging manufacturers to develop, test, refine, and commercialise vaccine-related products, technologies, and services, while building a pipeline of talent for local vaccine manufacturing.
The business model is built on blended revenue and catalytic support. This includes programme funding, service-based income from laboratory access and technical support, venture support fees, training programmes, and strategic partnerships with public and private sector stakeholders. This approach helps de-risk innovation while building long-term sustainability.
Operationally, the platform integrates shared infrastructure, technical advisory, business incubation, manufacturing readiness support, and ecosystem convening. Ventures and partners receive structured support across product development, process optimisation, quality and regulatory readiness, business model refinement, and access to customers, funders, and industry collaborators. In parallel, UVU Bio delivers targeted training in vaccine manufacturing, bioprocessing, quality systems, and entrepreneurship to strengthen local capabilities.
The project will contribute to more resilient healthcare infrastructure, local vaccine production capacity, job creation, and innovation-led industrial growth in Rwanda.
Team
Our team brings together expertise in biotechnology, enterprise development, innovation support, skills training, research, and commercialization. We combine technical, business, and ecosystem-building capabilities to help ventures and projects move from idea to implementation. With experience across South Africa and Rwanda, the team supports product development, entrepreneur capacity building, partnership development, and market-oriented innovation.
Contact person: Dheepak Maharajh – Mr (South Africa)
Type of Project
Governmental/Institutional project
Stage
Established (mature)
Annual Revenue (in EUR)
2025: 10.000 - 50.000 EUR
2024: 10.000 - 50.000 EUR
2023: 10.000 - 50.000 EUR
Number of employees
11-50
Total Project Cost (in EUR)
2,000,000 Euro
Financing needs (in EUR)
2,000,000 Euro
Type of financing needed
Venture Capital, Grant funding
The Company is looking for
Financing
Planned allocation of fundraising capital
Expansion (expanding an existing activity)